Drug intelligence / Profile preview

influenza virus vaccine (Institute of Medical Biology, Chinese Academy of Medical Sciences)

Development stage
Unknown
Lead developer
Institute of Medical Biology Chinese Academy of Medical Sciences
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

This is a preservative-free, inactivated split-virion influenza vaccine developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences (IMB, CAMS). Produced using an egg-based platform, the vaccine is designed to provide active immunization against seasonal influenza. It is specifically formulated for pediatric use in children aged 6 to 36 months, with a 0.25 mL dose containing 7.5 μg of hemagglutinin (HA) per strain. The vaccine is trivalent, containing antigens from two influenza A subtypes and one influenza B lineage. It has undergone Phase 3 clinical testing to evaluate its safety and immunogenicity compared to preservative-containing formulations in the Chinese pediatric population.

Other names
Influenza Virus Vaccine (Split Virion, Inactivated)Preservative-free inactivated split influenza vaccineIMB CAMS influenza vaccine
02

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on influenza virus vaccine (Institute of Medical Biology, Chinese Academy of Medical Sciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on influenza virus vaccine (Institute of Medical Biology, Chinese Academy of Medical Sciences).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call